Systemic bevacizumab for treatment of respiratory papillomatosis: international consensus statement

DR Sidell, K Balakrishnan, SR Best, K Zur… - The …, 2021 - Wiley Online Library
Objectives/Hypothesis The purpose of this study is to develop consensus on key points that
would support the use of systemic bevacizumab for the treatment of recurrent respiratory …
被引用次数：35 相关文章

Systemic Bevacizumab for Treatment of Respiratory Papillomatosis: International Consensus Statement

DR Sidell, K Balakrishnan, SR Best, K Zur… - …, 2021 - mayoclinic.elsevierpure.com
Objectives/Hypothesis: The purpose of this study is to develop consensus on key points that
would support the use of systemic bevacizumab for the treatment of recurrent respiratory …

Systemic Bevacizumab for Treatment of Respiratory Papillomatosis: International Consensus Statement

DR Sidell, K Balakrishnan, SR Best, K Zur… - 2021 - dh.howard.edu
Objectives/Hypothesis: The purpose of this study is to develop consensus on key points that
would support the use of systemic bevacizumab for the treatment of recurrent respiratory …

Systemic Bevacizumab for Treatment of Respiratory Papillomatosis: International Consensus Statement

DR Sidell, K Balakrishnan, SR Best… - The …, 2021 - pubmed.ncbi.nlm.nih.gov
Objectives/hypothesis The purpose of this study is to develop consensus on key points that
would support the use of systemic bevacizumab for the treatment of recurrent respiratory …

Systemic Bevacizumab for Treatment of Respiratory Papillomatosis: International Consensus Statement.

DR Sidell, K Balakrishnan, SR Best, K Zur… - …, 2021 - search.ebscohost.com
Abstract Objectives/Hypothesis: The purpose of this study is to develop consensus on key
points that would support the use of systemic bevacizumab for the treatment of recurrent …

Systemic Bevacizumab for Treatment of Respiratory Papillomatosis: International Consensus Statement

DR Sidell, K Balakrishnan, SR Best, K Zur… - …, 2021 - scholars.northwestern.edu
Objectives/Hypothesis: The purpose of this study is to develop consensus on key points that
would support the use of systemic bevacizumab for the treatment of recurrent respiratory …

Systemic bevacizumab for treatment of respiratory papillomatosis: international consensus statement.

DR Sidell, K Balakrishnan, SR Best, K Zur… - 2021 - cabidigitallibrary.org
Objectives/hypothesis: The purpose of this study is to develop consensus on key points that
would support the use of systemic bevacizumab for the treatment of recurrent respiratory …

Systemic Bevacizumab for Treatment of Respiratory Papillomatosis: International Consensus Statement.

DR Sidell, K Balakrishnan, SR Best, K Zur… - The …, 2021 - europepmc.org
Methods A multidisciplinary, multi-institutional panel of physicians with experience using
systemic bevacizumab for the treatment of RRP was established. The Delphi method was …

Systemic Bevacizumab for Treatment of Respiratory Papillomatosis: International Consensus Statement

DR Sidell, K Balakrishnan, SR Best… - …, 2021 - utsouthwestern.elsevierpure.com
Objectives/Hypothesis: The purpose of this study is to develop consensus on key points that
would support the use of systemic bevacizumab for the treatment of recurrent respiratory …

Systemic Bevacizumab for Treatment of Respiratory Papillomatosis: International Consensus Statement

DR Sidell, K Balakrishnan, SR Best, K Zur… - …, 2021 - ohsu.elsevierpure.com
Objectives/Hypothesis: The purpose of this study is to develop consensus on key points that
would support the use of systemic bevacizumab for the treatment of recurrent respiratory …